Latest Mesalazine Stories
LEXINGTON, Massachusetts, April 6, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) acknowledges the two petitions filed with the U.S. Patent and Trademark Office
RHEINFELDEN, Switzerland, February 20, 2015 /PRNewswire/ -- - Inflammatory bowel diseases (IBDs), such as ulcerative colitis (UC), affect up to
DALLAS, February 4, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Ulcerative Colitis - Pipeline Review, H1 2015" to its store.
FREIBURG and HEIDELBERG, Germany, October 29, 2014 /PRNewswire/ -- Positive FDA feedback on the protocol for the US Phase III trial with LT-02,
- Terms Unchanged from Previously Disclosed Agreement - DUBLIN, June 9, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has finalized its previously announced
DUBLIN, March 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has reversed a lower court ruling that Actavis'
OKLAHOMA CITY, Feb.
OKLAHOMA CITY, Jan. 29, 2014 /PRNewswire/ -- Altheus Therapeutics, Inc.
OKLAHOMA CITY, Jan.
- A person in a secondary role, specifically the second most important character (after the protagonist).